Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial.

Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gérard P, Magis D.

Neurology. 2013 Feb 19;80(8):697-704. doi: 10.1212/WNL.0b013e3182825055. Epub 2013 Feb 6.

PMID:
23390177
2.

Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.

De Brabander I, Yperzeele L, Ceuterick-De Groote C, Brouns R, Baker R, Belachew S, Delbecq J, De Keulenaer G, Dethy S, Eyskens F, Fumal A, Hemelsoet D, Hughes D, Jeangette S, Nuytten D, Redondo P, Sadzot B, Sindic C, Sheorajpanday R, Thijs V, Van Broeckhoven C, De Deyn PP.

Clin Neurol Neurosurg. 2013 Jul;115(7):1088-93. doi: 10.1016/j.clineuro.2012.11.003. Epub 2012 Dec 4.

PMID:
23219219
3.

[Bithalamic lesion. Report of a case].

Lechien J, Stricker J, Foulon P, Jeangette S, Bruninx G, Esposito A.

Rev Med Brux. 2010 Nov-Dec;31(6):539-43. French. No abstract available.

PMID:
21290859
4.

Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease.

Brouns R, Thijs V, Eyskens F, Van den Broeck M, Belachew S, Van Broeckhoven C, Redondo P, Hemelsoet D, Fumal A, Jeangette S, Verslegers W, Baker R, Hughes D, De Deyn PP; BeFaS Investigators.

Stroke. 2010 May;41(5):863-8. doi: 10.1161/STROKEAHA.110.579409. Epub 2010 Apr 1.

5.

First-ever stroke as initial presentation of systemic cancer.

Taccone FS, Jeangette SM, Blecic SA.

J Stroke Cerebrovasc Dis. 2008 Jul-Aug;17(4):169-74. doi: 10.1016/j.jstrokecerebrovasdis.2008.01.007.

PMID:
18589335

Supplemental Content

Loading ...
Support Center